USPTO serial 99752399
Serial No. 99752399
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GARTNER, JOHN M
- Law office
- TMO LAW OFFICE 119
What this means
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
Need help with Serial No. 99752399?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chuncheon-si, Gangwon-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Youngjoon Jung
David Youngjoon Jung KAIROS Law Firm, PLLC2001 L Street N.W. Suite 500Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations containing botulinum toxin for the treatment of facial lines, wrinkles, facial asymmetries, skin conditions and disorders of the human face and neck; Pharmaceutical preparations for the treatment of wrinkles, containing botulinum toxin; Pharmaceutical preparations for the treatment of wrinkles, containing botulinum toxin fragments; Botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, and skin disorders; Bacterial poisons; Pharmaceutical preparations for skin care; Pharmaceutical preparations used in cosmetic surgery; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of spasm; Pharmaceutical preparations for the treatment of dystonia; Muscle relaxants; Pharmaceutical agents for epidermis; Biological preparations for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; Bacteriological preparations for medical and veterinary use; Adjuvants for medical purposes; Medicinal creams for skin care; Pharmaceutical preparations for the treatment of wrinkles; Therapeutic pharmaceutical for the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, and skin disorders; Biological preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis and cerebral palsy; Biological preparations for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; Syringes sold filled with medical botulinum toxin as the main ingredient; Pharmaceutical preparations for the treatment of urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; Pharmaceutical preparations for the treatment of muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; Pharmaceutical preparations for the treatment of hyperhidrosis; Pharmaceutical preparations for the treatment of peripheral nervous systems; Pharmaceutical preparations for the treatment of the central nervous system; Migraine treatment preparations | ACTIVE | Jul 30, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 19, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |